000			01405 a2200421 4500
005			20250514000058.0
264		0	_c20010823
008			200108s 0 0 eng d
022			_a0924-8579
024	7		_a10.1016/s0924-8579(01)00300-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aKrcmery, V
245	0	0	_aFungaemia in elderly patients. _h[electronic resource]
260			_bInternational journal of antimicrobial agents _cMay 2001
300			_a419-21 p. _bdigital
500			_aPublication Type: Duplicate Publication; Letter
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAmphotericin B _xtherapeutic use
650	0	4	_aAntifungal Agents _xtherapeutic use
650	0	4	_aCandidiasis _xdrug therapy
650	0	4	_aCross Infection _xdrug therapy
650	0	4	_aFemale
650	0	4	_aFluconazole _xtherapeutic use
650	0	4	_aFlucytosine _xtherapeutic use
650	0	4	_aFungemia _xdrug therapy
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aPostoperative Complications _xdrug therapy
650	0	4	_aRisk Factors
650	0	4	_aSlovakia _xepidemiology
650	0	4	_aSurvival Rate
700	1		_aJurga, L
700	1		_aMateicka, F
700	1		_aSulcová, M
773	0		_tInternational journal of antimicrobial agents _gvol. 17 _gno. 5 _gp. 419-21
856	4	0	_uhttps://doi.org/10.1016/s0924-8579(01)00300-4 _zAvailable from publisher's website
999			_c11270292 _d11270292